永耀集團控股(08022.HK)繼續與專業顧問合作以推進復牌進展
格隆匯5月30日丨永耀集團控股(08022.HK)公吿,截至今日,董事會已向集團確定了一些新業務,並與外部第三方進行了各種談判,並希望在談判取得富有成果時,能再次發佈進一步的公吿。
公司於2022年5月10日召開特別股東大會,並且相關決議的議決案獲得股東的支持,包括通過一般授權發行股票和回購公司的股份。
為滿足復牌指引的要求,公司將繼續與專業顧問合作以推進復牌進展並將適時就其業務運營(包括債務重組計劃、注入新業務、第三方投資資金等)及復牌情況作出進一步公吿,以知會公司股東及潛在投資者。繼續暫停買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.